- Home
- About Us
Our story
The Rising T1DE Alliance (RTA) is a collective of like-minded organizations committed to revolutionizing Type 1 diabetes care through data-driven, patient-centered care. Our approach is proactive, not reactive. Founded in 2016 at Children's Mercy in Kansas City through a grant from The Leona M. and Harry B. Helmsley Charitable Trust (Helmsley), RTA began its innovation journey with a focus on proactively identifying and addressing clinical risks through actionable, timely insights. Follow-on funding in 2020 helped create the Diabetes Data Dock (D-Data Dock), a cloud-based population health management software that integrates data from the electronic health record (EHR), self-management devices, patient reported outcome surveys, and other sources. In 2024, a new grant from Helmsley added Ann & Robert H. Lurie Children’s Hospital of Chicago to RTA’s leadership team to create a dissemination framework to share the technologies, methods, and workflows developed by RTA across the diabetes ecosystem.
Together, we are reimagining diabetes care into a new paradigm that continuously and seamlessly integrates data, technology, and personalized care delivery. Our goal is to build and disseminate the technologies and practices to enable every healthcare organization to deliver the high quality, data driven care that every person with diabetes deserves.
.png)
Today RTA is focused on
iCoDE
Supporting integration of diabetes data into the EHR, incorporating many of the standards and recommendations developed by the Integration of Continuous Glucose Monitoring Data into the Electronic Health Record (iCoDE) Project.
D-Data Dock
Packaging the D-Data Dock software to make it simple and cost effective to share and deploy.
Predictive modeling
Advancing our predictive models and care interventions to make them more effective.
Toolkit
Developing toolkits to support other organizations to adopt both our technologies and rapid learning methodology to integrate data into iterative care model design.
Community support
Building a supportive community of innovators interested in optimizing diabetes population health management and creating sustainable operational models to support it.
Mission
To revolutionize Type 1 diabetes care through data-driven, patient-centered care.
Vision
Reimagine diabetes care into a paradigm that continuously and seamlessly integrates data, technology, and personalized care delivery while enabling rapid learning to optimize health outcomes.
Values
Patient-Centered Care: We place people and their lived experiences at the core of all our efforts, ensuring that every intervention and decision supports individual needs and enhances overall well-being.
Data-Driven Innovation: We continuously push the boundaries of healthcare innovation, using advanced analytics and machine learning to transform real-time health data into actionable insights to guide patient care.
Learning and Adaptability: Our approach is rooted in implementation science, allowing us to refine and enhance our interventions through iterative testing and continuous learning to adapt to evolving healthcare needs.
Collaboration and Advocacy: We drive impactful change that leverages the strengths of our diverse network of healthcare institutions, patient advocacy groups, and research organizations for a united approach to diabetes care.
Integrity and Transparency: We uphold the highest ethical standards, sharing our findings and methodologies openly to encourage widespread improvement and adoption.
Equity and Access: Everyone deserves access to high-quality diabetes care, and we work to dismantle barriers, promoting scalable solutions that bring advanced, personalized care to diverse communities.
Sustainability: We aim to create tools that enable economically viable care across a variety of healthcare settings to create value for patients, health care systems, and payors.
Download our reports
Artificial Intelligence and Personalized Medicine in Diabetes Care
To hear more about the Rising T1DE Alliance, watch Dr. Mark Clements’ presentation “Artificial Intelligence and Personalized Medicine in Diabetes Care” at an Advanced Technologies and Treatments for Diabetes (ATTD) conference.